NCT01347424

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Sun Yat-sen University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Contrast enhancement ultrasonography（CEUS）could be used to evaluate the blood flow perfusion liver cancer. In this clinical trial, CEUS was used to evaluated the changes of blood flow perfusion of Secondary Malignant Neoplasm of Liver after treated with endostatin plus paclitaxel and carboplatin regimen.

Conditions

• Non Small Cell Lung Cancer
• Nasopharyngeal Cancer
• Liver Metastasis

Interventions

Type	Name	Description
DRUG	Paclitaxel , carboplatin, endostatin	PTX：175mg/m2，D1, q3w CBP：AUC5，D1, q3w endostatin：7.5 mg/m2 iv 3-4h， d1～15，q3w
DRUG	Paclitaxel and Carboplatin	PTX：175mg/m2，D1, q3w CBP：AUC5，D1, q3w

Timeline

• Start date: 2011-01-01
• Primary completion: 2014-05-01
• Completion: 2014-10-01
• First posted: 2011-05-04
• Last updated: 2013-12-09

Locations

1 site across 1 country: China